These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 17902119)

  • 41. Comparison of single and multiple agency clients in substance abuse treatment services.
    Colpaert K; Vanderplasschen W; Broekaert E
    Eur Addict Res; 2007; 13(3):156-66. PubMed ID: 17570912
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magistrates' Early Referral into Treatment (MERIT): preliminary findings of a 12-month court diversion trial for drug offenders.
    Reilly D; Scantleton J; Didcott P
    Drug Alcohol Rev; 2002 Dec; 21(4):393-6. PubMed ID: 12537710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments.
    Henggeler SW; Halliday-Boykins CA; Cunningham PB; Randall J; Shapiro SB; Chapman JE
    J Consult Clin Psychol; 2006 Feb; 74(1):42-54. PubMed ID: 16551142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment during transition from prison to community and subsequent illicit drug use.
    Butzin CA; Martin SS; Inciardi JA
    J Subst Abuse Treat; 2005 Jun; 28(4):351-8. PubMed ID: 15925269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dilemmas of expert opinion and coercive treatment according to section sign 64 German penal code].
    Hoffmann K; Mielke R; Dressing H
    Psychiatr Prax; 2006 Nov; 33(8):398-400. PubMed ID: 17128398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated services plus drug treatment as a system alternative to crime control and parole.
    Danzer G
    Soc Work Public Health; 2012; 27(7):687-98. PubMed ID: 23145552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Value of drug screening in granting leave of absence to prisoners].
    Lapornik R; Zapotoczky HG
    Wien Klin Wochenschr; 1998 Nov; 110(21):755-8. PubMed ID: 9871967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Status of the management of addicted patients--results of an expert survey as the basis for health policy decisions].
    Fleischmann H; Krischker S
    Gesundheitswesen; 1996 Oct; 58(10):538-42. PubMed ID: 9035784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of community-based treatment for substance-abusing adolescents: 12-month outcomes of youths entering phoenix academy or alternative probation dispositions.
    Morral AR; McCaffrey DF; Ridgeway G
    Psychol Addict Behav; 2004 Sep; 18(3):257-68. PubMed ID: 15482081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized clinical trial of a therapeutic community treatment for female inmates: outcomes at 6 and 12 months after prison release.
    Sacks JY; McKendrick K; Hamilton Z
    J Addict Dis; 2012; 31(3):258-69. PubMed ID: 22873187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The epidemiology of psychiatric disorders among repeat DUI offenders accepting a treatment-sentencing option.
    Shaffer HJ; Nelson SE; LaPlante DA; LaBrie RA; Albanese M; Caro G
    J Consult Clin Psychol; 2007 Oct; 75(5):795-804. PubMed ID: 17907861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug consumption among sexual offenders against females.
    Baltieri DA; de Andrade AG
    Int J Offender Ther Comp Criminol; 2008 Feb; 52(1):62-80. PubMed ID: 17615431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anxiety and substance use: layers of complexity.
    Castle DJ
    Expert Rev Neurother; 2008 Mar; 8(3):493-501. PubMed ID: 18345977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Female prisoners with borderline personality disorder: some promising treatment developments.
    Nee C; Farman S
    Crim Behav Ment Health; 2005; 15(1):2-16. PubMed ID: 16470495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The significance of psychotropic substance abuse and addiction in the treatment of psychosomatic rehabilitation patients].
    Wiehn T; Domma J; Vollmer HC
    Rehabilitation (Stuttg); 2008 Jun; 47(3):158-63. PubMed ID: 18553246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of therapeutic engagement in prison-based drug treatment.
    Welsh WN; McGrain PN
    Drug Alcohol Depend; 2008 Aug; 96(3):271-80. PubMed ID: 18486361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improving services for prevention and treatment of substance misuse for Aboriginal communities in a Sydney Area Health Service.
    Teasdale KE; Conigrave KM; Kiel KA; Freeburn B; Long G; Becker K
    Drug Alcohol Rev; 2008 Mar; 27(2):152-9. PubMed ID: 18264875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Forensic issues in intellectual disability.
    Søndenaa E; Rasmussen K; Nøttestad JA
    Curr Opin Psychiatry; 2008 Sep; 21(5):449-53. PubMed ID: 18650685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An outcome evaluation of prison-based treatment programming for substance users.
    Porporino FJ; Robinson D; Millson B; Weekes JR
    Subst Use Misuse; 2002; 37(8-10):1047-77. PubMed ID: 12180555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.